Stay updated on BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial
Sign up to get notified when there's something new on the BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial page.

Latest updates to the BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 was added and revision: v3.4.2 was removed.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added; the government funding notice and Revision: v3.4.1 were removed.SummaryDifference0.3%

- Check41 days agoChange DetectedAdded a site-wide funding/operational notice and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.3%

- Check48 days agoChange DetectedAdditions: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check84 days agoChange DetectedA consolidated Locations section has been added, listing study sites by state (Arizona, Arkansas, California, Colorado, Florida, Illinois, Iowa, Maryland, Michigan, New Jersey, Ohio, Oklahoma, Virginia, Washington) and the previous individual state location subsections have been removed. The HHS Vulnerability Disclosure link was removed and the revision updated from v3.3.2 to v3.3.3.SummaryDifference1%

Stay in the know with updates to BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BeyoND Study: ND0612 Safety in Advanced PD Clinical Trial page.